Cat. No.
MABL-3618
Application
in vivo, neutralizing, SPR
Isotype
Engineer antibody
Species Reactivity
Monkeypox virus, Vaccinia virus
Clone No.
M1R-01
From
Recombinant Antibody
Specificity
The original antibody specifically targets the core antigen M1R of the monkeypox virus. The antibody binds to a conformational epitope encompassing α3 (A94–L95), α4 (Y111 and T113), α5 (N157, C158, K161, and Q165), α4' (V121) the loop connecting α4' and β3 (N130), β3 (V131–133), β4 (F148), along with the sporadic residues I38, N96, D134 on M1R protein. The antibody cross reacts with the vaccinia virus.
Alternative Names
M1-01; M1R protein; Entry-fusion complex associated protein OPG095; EFC-associated protein OPG095; Protein L1
UniProt
M1LBP0
Immunogen
The original antibody was generated by panning a nanobody display library against M1R.
Application Notes
The binding affinity of the original format of the antibody and the mouse Fc version of the antibody to M1R protein was measured by surface plasmon resonance (Kd= 43 nM and 1.79 nM respectively). Neutralization activity of the original format of the antibody and the murine Fc version of the antibody was tested on BS-C-1 cells infected with VACV. The neutralization NT 50 value of the original fragment was 28.04 μg/mL, and the neutralization NT 50 value of the mFc fusion variant of the antibody was 1.99 μg/mL (CN120329422A). The crystal structure of the antibody in complex with M1R protein was determined. Binding affinity of the original format of the antibody and mFc formats of the antibody were measured by SPR analysis (Kd = 40.38 nM and 1.79 nM respectively). The two variants could neutralize the intracellular mature virions of modified vaccinia Ankara (MVA) (IC50 = 16.14 for the original format of the antibody and 2.22 for the mFc version) and VACV-WR (IC50 = 26.47 for the original format of the antibody and 3.13 for the mFc version). Further, the mFc variant could neutralize MPXV (IC50= 67.24 respectively). Intraperitoneal injection of the human IgG1-Fc fusion version of the antibody protected mice from fatal VACV challenge. Studies were conducted with the bivalent and trivalent versions of the antibody (Yang et al., 2025; PMID: 40133273). These versions are available upon request.
Antibody First Published
Yang et al. Identification of neutralizing nanobodies protecting against poxvirus infection Cell Discov. 2025 Mar 25;11(1):31. doi: 10.1038/s41421-025-00771-7. PMID:40133273
Note on publication
The original paper describes the generation and characterization of the antibody.
Size
100 μg Purified antibody.
Concentration
1 mg/ml.
Purification
Protein A affinity purified
Buffer
PBS with 0.02% Proclin 300.
Storage Recommendation
Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C.


